US Congress Subject | Drug therapy

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
USHB3263IntroTo amend the Homeland Security Act of 2002 to establish in the Department of Homeland Security a medical countermeasures program, and for other purposes.
[Detail][Text][Discuss]
2021-06-01
Placed on the Union Calendar, Calendar No. 32.
USHB3125EngrossTo enhance authorities under the Defense Production Act of 1950 to respond to the COVID-19 emergency, to provide additional oversight of such authorities, and for other purposes.
[Detail][Text][Discuss]
2021-05-19
To Senate Banking, Housing, And Urban Affairs Committee
USHB1647IntroModifies requirements relating to coverage of certain telehealth services under Medicare. Specifically, the bill permanently allows telehealth services for substance-use disorders and mental health disorders to be provided via audio-only technology, ...
[Detail][Text][Discuss]
2021-05-18
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB1927IntroModifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and ...
[Detail][Text][Discuss]
2021-05-18
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB1686IntroRequires the Government Accountability Office to report on the availability of and unmet need for substance use disorder treatment and recovery services, including for specified populations. The report must also address barriers to real-time reportin...
[Detail][Text][Discuss]
2021-05-07
To House Subcommittee for Indigenous Peoples of the United States
USSB1457IntroA bill to establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids, and for other purposes.
[Detail][Text][Discuss]
2021-04-29
To Senate Health, Education, Labor, And Pensions Committee
USHB1391IntroRequires the Department of Health and Human Services (HHS) to coordinate with specified federal entities to compile a public database of federal contracts, tax benefits, and other support for COVID-19 (i.e., coronavirus disease 2019) biomedical resea...
[Detail][Text][Discuss]
2021-04-28
To House Subcommittee on Courts, Intellectual Property, And The Internet
USHB1384IntroTo amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment...
[Detail][Text][Discuss]
2021-04-28
To House Subcommittee on Crime, Terrorism, and Homeland Security
USHB3IntroEstablishes several programs and requirements relating to the prices of prescription drugs. In particular, the bill requires the Department of Health and Human Services (HHS) to negotiate prices for certain drugs (current law prohibits HHS from doing...
[Detail][Text][Discuss]
2021-04-27
To House Subcommittee on Oversight and Investigations
USSB578PassExpands the definition of major food allergen for purposes of certain food-labeling requirements to specifically include sesame. In addition, the Department of Health and Human Services must report on certain information related to food allergy resea...
[Detail][Text][Discuss]
2021-04-23
Became Public Law No: 117-11. (TXT | PDF)
USHB19IntroTo provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes.
[Detail][Text][Discuss]
2021-04-22
To House Subcommittee on Health
USHB2636IntroTo direct the Secretary of Health and Human Services to submit to Congress a report on the security and resilience of the United States medical supply chains, and for other purposes.
[Detail][Text][Discuss]
2021-04-16
To House Energy And Commerce Committee
USSB1176IntroA bill to establish a grant program to support the manufacture and stockpiling of essential generic antibiotic drugs.
[Detail][Text][Discuss]
2021-04-15
To Senate Health, Education, Labor, And Pensions Committee
USSB1125IntroAllows the Center for Medicare and Medicaid Innovation (CMMI) to test a Dementia Care Management Model that provides comprehensive care to Medicare beneficiaries with Alzheimer's disease or a related dementia. Under the model, participating health ca...
[Detail][Text][Discuss]
2021-04-14
To Senate Finance Committee
USHB2366IntroTo establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids, and for other purposes.
[Detail][Text][Discuss]
2021-04-13
To House Subcommittee on Health
USHB2185IntroTo amend title XIX and XXI of the Social Security Act to provide coverage of comprehensive tobacco cessation services under such titles, and for other purposes.
[Detail][Text][Discuss]
2021-03-26
To House Energy And Commerce Committee
USSB987IntroA bill to provide support with respect to the prevention of, treatment for, and recovery from, substance use disorder.
[Detail][Text][Discuss]
2021-03-25
To Senate Health, Education, Labor, And Pensions Committee
USSB1010IntroA bill to provide funding for programs and activities under the SUPPORT for Patients and Communities Act.
[Detail][Text][Discuss]
2021-03-25
To Senate Health, Education, Labor, And Pensions Committee
USSB1046IntroA bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the residential substance use disorder treatment program, and for other purposes.
[Detail][Text][Discuss]
2021-03-25
To Senate Judiciary Committee
USHB2179IntroEliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows ben...
[Detail][Text][Discuss]
2021-03-23
To House Energy And Commerce Committee
USHB2125IntroTo amend title XIX and XXI of the Social Security Act to provide coverage of comprehensive tobacco cessation services under such titles, and for other purposes.
[Detail][Text][Discuss]
2021-03-23
To House Energy And Commerce Committee
USHB2163IntroRequires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a heal...
[Detail][Text][Discuss]
2021-03-23
To House Education and Labor Committee
USHB597IntroImposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies. With respect to a COVID-19 drug patent developed using certain...
[Detail][Text][Discuss]
2021-03-22
To House Subcommittee on Courts, Intellectual Property, And The Internet
USHB2036IntroTo direct the Secretary of Health and Human Services, in consultation with the Secretary of State, to formulate a strategy for entering into agreements with foreign countries to develop and commercialize new drugs to address pandemics, and for other ...
[Detail][Text][Discuss]
2021-03-18
To House Foreign Affairs Committee
USSB777IntroModifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and ...
[Detail][Text][Discuss]
2021-03-16
To Senate Finance Committee
USHB1319PassProvides additional relief to address the continued impact of COVID-19 (i.e., coronavirus disease 2019) on the economy, public health, state and local governments, individuals, and businesses. TITLE I--COMMITTEE ON AGRICULTURE, NUTRITION, AND FORESTR...
[Detail][Text][Discuss]
2021-03-11
Became Public Law No: 117-2.
USHB1829IntroRequires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates ...
[Detail][Text][Discuss]
2021-03-11
To House Energy And Commerce Committee
USSB670IntroA bill to amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.
[Detail][Text][Discuss]
2021-03-10
To Senate Health, Education, Labor, And Pensions Committee
USHB1730IntroTo amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.
[Detail][Text][Discuss]
2021-03-10
To House Energy And Commerce Committee
USSB586IntroTemporarily establishes separate payments for certain non-opioid treatments under the Medicare prospective payment system for hospital outpatient department services and the payment system for ambulatory surgical center services. The bill applies to ...
[Detail][Text][Discuss]
2021-03-04
To Senate Finance Committee
USHB1456IntroTo amend the Peace Corps Act to reauthorize the Peace Corps, better support current and returned volunteers, and for other purposes.
[Detail][Text][Discuss]
2021-03-01
To House Foreign Affairs Committee
USHB1371IntroMaking supplemental appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes.
[Detail][Text][Discuss]
2021-02-25
To House Appropriations Committee
USSB482IntroRequires the Department of Health and Human Services (HHS) to coordinate with specified federal entities to compile a public database of federal contracts, tax benefits, and other support for COVID-19 (i.e., coronavirus disease 2019) biomedical resea...
[Detail][Text][Discuss]
2021-02-25
To Senate Health, Education, Labor, And Pensions Committee
USSB464IntroRequires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a heal...
[Detail][Text][Discuss]
2021-02-25
To Senate Health, Education, Labor, And Pensions Committee
USSB445IntroA bill to amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V, such as buprenorphine, for maintenance or detoxification tr...
[Detail][Text][Discuss]
2021-02-25
To Senate Health, Education, Labor, And Pensions Committee
USHB1202IntroExpands the definition of major food allergen for purposes of certain food-labeling requirements to specifically include sesame. In addition, the Department of Health and Human Services must report on certain information related to food allergy resea...
[Detail][Text][Discuss]
2021-02-23
To House Subcommittee on Health
USSB340IntroModifies requirements relating to coverage of certain telehealth services under Medicare. Specifically, the bill permanently allows telehealth services for substance-use disorders and mental health disorders to be provided via audio-only technology, ...
[Detail][Text][Discuss]
2021-02-22
To Senate Health, Education, Labor, And Pensions Committee
USHB1184IntroAddresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process. The bill also requires certain reports to address issues r...
[Detail][Text][Discuss]
2021-02-19
To House Subcommittee on Health
USHB975IntroRequires prescription drug plans under Medicare and Medicare Advantage to cover drugs that are approved to treat COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency.
[Detail][Text][Discuss]
2021-02-12
To House Subcommittee on Health
USHB918IntroAllows COVID-19 (i.e., coronavirus disease 2019) vaccines, prevention, and treatment, as well as prevention and treatment for conditions that may complicate COVID-19 treatment, for uninsured individuals to be covered under Medicaid during the public ...
[Detail][Text][Discuss]
2021-02-09
To House Subcommittee on Health
USSB274IntroAllows COVID-19 (i.e., coronavirus disease 2019) vaccines, prevention, and treatment, as well as prevention and treatment for conditions that may complicate COVID-19 treatment, for uninsured individuals to be covered under Medicaid during the public ...
[Detail][Text][Discuss]
2021-02-08
To Senate Finance Committee
USSB298IntroRequires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates ...
[Detail][Text][Discuss]
2021-02-08
To Senate Health, Education, Labor, And Pensions Committee
USHB853IntroRevises the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to trea...
[Detail][Text][Discuss]
2021-02-05
To House Subcommittee on Health
USHB67IntroRequires the Department of Veterans Affairs (VA) to contract with the National Academies of Sciences, Engineering, and Medicine to report on the deaths of covered veterans who died by suicide during the last five years, regardless of whether informat...
[Detail][Text][Discuss]
2021-02-04
To House Subcommittee on Health
USSB253IntroA bill to expand research on the cannabidiol and marihuana.
[Detail][Text][Discuss]
2021-02-04
To Senate Judiciary Committee
USHB467IntroRequires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
[Detail][Text][Discuss]
2021-02-02
To House Subcommittee on Health
USSB176IntroRequires the National Institutes of Health (NIH), in consultation with the Centers for Disease Control and Prevention, to conduct a longitudinal study on the health impacts of COVID-19 (i.e., coronavirus disease 2019). The NIH must provide public sum...
[Detail][Text][Discuss]
2021-02-02
To Senate Health, Education, Labor, And Pensions Committee
Syndicate content
feedback